Atlas Brown Inc. held its position in Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel reports. The institutional investor owned 4,280 shares of the insurance provider’s stock at the end of the second quarter. Atlas Brown Inc.’s holdings in Humana were worth $770,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. LMR Partners LLP raised its position in Humana by 1.6% in the second quarter. LMR Partners LLP now owns 92,500 shares of the insurance provider’s stock worth $16,639,000 after buying an additional 1,500 shares during the period. Savant Capital LLC raised its position in Humana by 1.3% in the second quarter. Savant Capital LLC now owns 2,380 shares of the insurance provider’s stock worth $428,000 after buying an additional 30 shares during the period. Huntington National Bank raised its position in Humana by 3.1% in the second quarter. Huntington National Bank now owns 16,134 shares of the insurance provider’s stock worth $2,902,000 after buying an additional 491 shares during the period. ING Groep NV bought a new position in Humana during the second quarter worth $945,000. Finally, Retirement Systems of Alabama raised its position in Humana by 0.7% in the second quarter. Retirement Systems of Alabama now owns 75,981 shares of the insurance provider’s stock worth $13,667,000 after buying an additional 531 shares during the period. 93.24% of the stock is owned by institutional investors.
Shares of Humana Inc. (NYSE:HUM) traded up 0.79% during trading on Friday, hitting $170.82. The stock had a trading volume of 1,447,892 shares. Humana Inc. has a 12-month low of $150.00 and a 12-month high of $191.65. The firm has a 50 day moving average price of $176.12 and a 200 day moving average price of $175.83. The firm has a market cap of $25.46 billion, a P/E ratio of 26.24 and a beta of 0.90.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.23 by $0.07. Humana had a return on equity of 11.11% and a net margin of 1.76%. The firm had revenue of $14 billion for the quarter, compared to the consensus estimate of $13.59 billion. During the same period in the prior year, the firm earned $1.67 EPS. The firm’s revenue was up 2.0% on a year-over-year basis. On average, equities analysts expect that Humana Inc. will post $9.24 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s payout ratio is 18.18%.
A number of research firms recently weighed in on HUM. Barclays PLC reaffirmed an “equal weight” rating and set a $191.00 price objective on shares of Humana in a research report on Friday. Susquehanna reissued a “neutral” rating and issued a $180.00 target price on shares of Humana in a report on Thursday. Royal Bank Of Canada reduced their target price on Humana from $222.00 to $217.00 and set a “sector perform” rating for the company in a report on Thursday. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a report on Tuesday, October 4th. Finally, Evercore ISI began coverage on Humana in a report on Thursday, September 22nd. They issued a “buy” rating and a $200.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $200.50.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.